---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-020896"
form_type: "8-K"
ticker: "AVR"
cik: "0002011514"
company_name: "Anteris Technologies Global Corp."
filed_at: "2026-05-13T00:39:53+00:00"
generated_at: "2026-05-13T10:21:51.736475+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Anteris raises $320M, Q1 cash burn $28.7M; PARADIGM trial enrols in US

## Summary
- Net operating cash outflows of $28.7M for Q1 2026, funding PARADIGM Trial and manufacturing scale-up.
- R&D expenses $17.5M, driven by clinical trial costs, manufacturing process validation, and headcount expansion.
- Completed $320M capital raises in January 2026 to support PARADIGM Trial and global commercialization of DurAVR THV.
- Post quarter-end, US patient enrollment in the PARADIGM Trial commenced; CMS coverage determination supports reimbursement.
- Presented EMBARK Study and EFS data at CRT 2026 and Sydney Valves 2026.

## SEC filing metadata
- accession: 0001140361-26-020896
- form_type: 8-K
- ticker: AVR
- cik: 0002011514
- company_name: Anteris Technologies Global Corp.
- filed_at: 2026-05-13T00:39:53+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2011514/000114036126020896/0001140361-26-020896-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2011514/000114036126020896/ef20072992_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-020896
- JSON: https://secwatch.observer/filing/0001140361-26-020896.json
- Plain text: https://secwatch.observer/filing/0001140361-26-020896.txt

## Key facts
- Earnings Releases
  Anteris Technologies Global Corp. reported financial results for first quarter of 2026.
  - Period: first quarter of 2026
  - Result: reported results
  source text: today reported financial results for the quarter ended 31 March 2026, and provided a corporate update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2011514/000114036126020896/0001140361-26-020896-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.